Editorial: The XXIIrd International Tuberculosis Conference.
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000009:adverse effects; D004334:Drug Administration Schedule; D005069:Evaluation Studies as Topic; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D010000:Osteitis / Q000209:etiology; D013307:Streptomycin / Q000008:administration & dosage; D014376:Tuberculosis / Q000517:prevention & control
D000995:Antitubercular Agents; D001500:BCG Vaccine; D007538:Isoniazid; D013307:Streptomycin